UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000054415
Receipt number R000061849
Scientific Title Japan Comprehensive Process for End-of-Life Care and Organ Donation After Brain Death
Date of disclosure of the study information 2024/07/01
Last modified on 2025/05/17 09:26:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Japan Comprehensive Process for End-of-Life Care and Organ Donation After Brain Death

Acronym

Japan Comprehensive Process for End-of-Life Care and Organ Donation After Brain Death

Scientific Title

Japan Comprehensive Process for End-of-Life Care and Organ Donation After Brain Death

Scientific Title:Acronym

J-RESPECT study

Region

Japan


Condition

Condition

Brain death

Classification by specialty

Emergency medicine Intensive care medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To provide a detailed overview and examination of the organ donation process in active institutions, focusing on understanding current practices to facilitate improvements in Japan's organ donation procedures, management, and systems.

Basic objectives2

Others

Basic objectives -Others

To examine the consent processes for legal brain death diagnosis and organ donation after brain death among Japanese institutions that have actively facilitated actual organ donations

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The number of organ donations after brain death

Key secondary outcomes

1. Time intervals from admission to the diagnosis of brain death, option presentation of organ donation to the family, and organ procurement
2. Time intervals from admission to the start of administration of antidiuretic hormone and steroids
3. The number of multidisciplinary team meetings
4. Characteristics of institutions that are active in organ donation after brain death


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients involved in organ donation after brain death

Key exclusion criteria

1. Patients whose families or representatives refuse to participate in the study.
2. Based upon each institution's decision, patients whose families or representatives refuse to disclose information on the webpage of the Japan Organ Transplant Network

Target sample size

250


Research contact person

Name of lead principal investigator

1st name Atsunori
Middle name
Last name Nakao

Organization

Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University

Division name

Department of Emergency, Critical Care and Disaster Medicine

Zip code

700-8558

Address

2-5-1 Shikata-cho, Kita-ku, Okayama

TEL

086-235-7426

Email

qq-nakao@okayama-u.ac.jp


Public contact

Name of contact person

1st name Tetsuya
Middle name
Last name Yumoto

Organization

Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University

Division name

Department of Emergency, Critical Care and Disaster Medicine

Zip code

700-8558

Address

2-5-1 Shikata-cho, Kita-ku, Okayama

TEL

086-235-7426

Homepage URL


Email

tyumoto@cc.okayama-u.ac.jp


Sponsor or person

Institute

Okayama University

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Okayama University Hospital Ethics Committee

Address

2-5-1 Shikata-cho, Kita-ku, Okayama

Tel

086-235-6938

Email

mae6605@adm.okayama-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 07 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

204

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2024 Year 08 Month 01 Day

Date of IRB

2024 Year 06 Month 28 Day

Anticipated trial start date

2024 Year 08 Month 01 Day

Last follow-up date

2024 Year 10 Month 31 Day

Date of closure to data entry


Date trial data considered complete

2024 Year 12 Month 31 Day

Date analysis concluded

2025 Year 03 Month 31 Day


Other

Other related information

The following data or information will be retrieved: signs of brain death, specialized management due to the physiological changes associated with brain death, multidisciplinary discussions on end-of-life care, and institutional organ donation systems.


Management information

Registered date

2024 Year 05 Month 16 Day

Last modified on

2025 Year 05 Month 17 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000061849